SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-114783
Filing Date
2020-10-14
Accepted
2020-10-14 12:01:52
Documents
6
Period of Report
2020-10-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2033155d1_8k.htm 8-K 23916
2 EXHIBIT 5.1 tm2033155d1_ex5-1.htm EX-5.1 13082
3 EXHIBIT 10.1 tm2033155d1_ex10-1.htm EX-10.1 254869
4 EXHIBIT 10.2 tm2033155d1_ex10-2.htm EX-10.2 137838
5 EXHIBIT 10.3 tm2033155d1_ex10-3.htm EX-10.3 147689
6 EXHIBIT 99.1 tm2033155d1_ex99-1.htm EX-99.1 16383
  Complete submission text file 0001104659-20-114783.txt   594927
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38630 | Film No.: 201238583
SIC: 2834 Pharmaceutical Preparations